lomefloxacin has been researched along with Pyrexia in 1 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Todd, I | 1 |
| Negm, OH | 1 |
| Reps, J | 1 |
| Radford, P | 1 |
| Figueredo, G | 1 |
| McDermott, EM | 1 |
| Drewe, E | 1 |
| Powell, RJ | 1 |
| Bainbridge, S | 1 |
| Hamed, M | 1 |
| Crouch, S | 1 |
| Garibaldi, J | 1 |
| St-Gallay, S | 1 |
| Fairclough, LC | 1 |
| Tighe, PJ | 1 |
1 other study available for lomefloxacin and Pyrexia
| Article | Year |
|---|---|
A signalome screening approach in the autoinflammatory disease TNF receptor associated periodic syndrome (TRAPS) highlights the anti-inflammatory properties of drugs for repurposing.
Topics: Adult; Anti-Inflammatory Agents; Cell Line, Tumor; Drug Repositioning; Female; Fever; Fluoroquinolon | 2017 |